Welcome
The Cardio-CARE at Medizincampus Davos, Switzerland, is funded by the Kühne Foundation. With 13 million Swiss Francs, it enables the largest research program to date for genome decoding in German-speaking regions. The main aims of our project are to
- better understand the genetic basic of cardiovascular diseases,
- improve its diagnosis, and
- identify drug targets.
This multidisciplinary project benefits from the intensive collaboration between the Kühne Foundation, the University Medical Center Zurich (USZ), and the University Medical Center Hamburg-Eppendorf (UKE).
“In future, diseases will be better avoided and cured if we help the medical profession to better understand the occurrence of disease in each individual.”
─ Prof. Dr. h.c. Klaus-Michael Kühne ─
Everything about Cardio-CARE
- Experts in pre-processing of large-scale high-throughput genome sequences.
- Experts in data analysis of high-throughput genome sequences.
- Long-standing experience in machine learning and artificial intelligence.
- Support planning, conduct and analysis of trials focusing on cardiovascular diseases and personalized medicine.
- Support planning, conduct and analysis of trials focusing on medical devices, such as telemonitoring.
- Perform friendly customer-oriented biostatistical and bioinformatical consulting.
News
Modifiable risk factors responsible for half of cardiovascular diseases
Scientists of the Global Cardiovascular Risk Consortium under the auspices of the Department of Cardiology at the University Heart & Vascular Center of the Medical
Cardio-CARE featured on Illumina
Can Genomics Stop the World’s Leading Cause of Death? Read the article on Illuminas website: Can Genomics Stop the World’s Leading Cause of Death? (illumina.com)